102 related articles for article (PubMed ID: 33788183)
1. Surufatinib: First Approval.
Syed YY
Drugs; 2021 Apr; 81(6):727-732. PubMed ID: 33788183
[TBL] [Abstract][Full Text] [Related]
2. Surufatinib combined with transarterial embolization versus surufatinib monotherapy in patients with liver metastatic neuroendocrine tumors: Study protocol for a prospective, randomized, controlled trial.
Li R; Li X; You X; Su M; Liu Y; Ke N; Cao D
Cancer Med; 2024 Apr; 13(8):e7131. PubMed ID: 38629255
[TBL] [Abstract][Full Text] [Related]
3. Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Cives M; Pelle' E; Strosberg J
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33202931
[TBL] [Abstract][Full Text] [Related]
4. Targeted Cancer Therapy: What's New in the Field of Neuroendocrine Neoplasms?
La Salvia A; Espinosa-Olarte P; Riesco-Martinez MDC; Anton-Pascual B; Garcia-Carbonero R
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916707
[TBL] [Abstract][Full Text] [Related]
5. Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors.
Lu X; Yan S; Koral KA; Chen Z
Expert Rev Anticancer Ther; 2021 Sep; 21(9):917-926. PubMed ID: 34142932
[No Abstract] [Full Text] [Related]
6. Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs).
Xu J
Ther Adv Med Oncol; 2021; 13():17588359211042689. PubMed ID: 34484432
[TBL] [Abstract][Full Text] [Related]
7. Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509).
Capdevila J; Fazio N; Lopez C; Teulé A; Valle JW; Tafuto S; Custodio A; Reed N; Raderer M; Grande E; Garcia-Carbonero R; Jimenez-Fonseca P; Hernando J; Bongiovanni A; Spada F; Alonso V; Antonuzzo L; Spallanzani A; Berruti A; La Casta A; Sevilla I; Kump P; Giuffrida D; Merino X; Trejo L; Gajate P; Matos I; Lamarca A; Ibrahim T
J Clin Oncol; 2021 Jul; 39(20):2304-2312. PubMed ID: 33945297
[TBL] [Abstract][Full Text] [Related]
8. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
9. Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer.
Murahashi M; Tsuruta T; Yamada K; Hijikata Y; Ogata H; Kishimoto J; Yoshimura S; Hikichi T; Nakanishi Y; Tani K
Anticancer Res; 2021 Mar; 41(3):1485-1496. PubMed ID: 33788741
[TBL] [Abstract][Full Text] [Related]
10. A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.
Falchook GS; Peeters M; Rottey S; Dirix LY; Obermannova R; Cohen JE; Perets R; Frommer RS; Bauer TM; Wang JS; Carvajal RD; Sabari J; Chapman S; Zhang W; Calderon B; Peterson DA
Invest New Drugs; 2021 Oct; 39(5):1284-1297. PubMed ID: 33852104
[TBL] [Abstract][Full Text] [Related]
11. Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
Schrank TP; Lenze N; Landess LP; Hoyle A; Parker J; Lal A; Sheth S; Chera BS; Patel SN; Hackman TG; Major MB; Issaeva N; Yarbrough WG
Cancer; 2021 Aug; 127(15):2788-2800. PubMed ID: 33819343
[TBL] [Abstract][Full Text] [Related]
12. A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors.
Listik E; Horst B; Choi AS; Lee NY; Győrffy B; Mythreye K
PLoS One; 2021; 16(4):e0249558. PubMed ID: 33819300
[TBL] [Abstract][Full Text] [Related]
13. Medullary thyroid cancer: molecular factors, management and treatment.
Pavlidis E; Sapalidis K; Chatzinikolaou F; Kesisoglou I
Rom J Morphol Embryol; 2020; 61(3):681-686. PubMed ID: 33817709
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanism of Secondary Endocrine Resistance in Luminal Breast Cancer.
Wu M; Ding J; Wen L; Zhou Y; Wu W
Biomed Res Int; 2021; 2021():6618519. PubMed ID: 33816619
[TBL] [Abstract][Full Text] [Related]
15. Bilateral Renal Angiomyolipomas and Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex: a Case Report and Review of The Literature.
Rambabova Bushljetik I; Lazareska M; Barbov I; Stankov O; Filipce V; Spasovski G
Balkan J Med Genet; 2020 Nov; 23(2):93-98. PubMed ID: 33816078
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of 38 novel patient-derived primary cancer cell lines using multi-region sampling revealing intra-tumor heterogeneity of gallbladder carcinoma.
Feng F; Cheng Q; Li B; Liu C; Wang H; Li B; Xu X; Yu Y; Chen Z; Wu X; Dong H; Chu K; Xie Z; Gao Q; Xiong L; Li F; Yi B; Zhang D; Jiang X
Hum Cell; 2021 May; 34(3):918-931. PubMed ID: 33813726
[TBL] [Abstract][Full Text] [Related]
17. A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3-Specific CAR T Cells in Solid Tumors.
Lei X; Ou Z; Yang Z; Zhong J; Zhu Y; Tian J; Wu J; Deng H; Lin X; Peng Y; Li B; He L; Tu Z; Chen W; Li Q; Liu N; Zhang H; Wang Z; Fang Z; Yamada T; Lv X; Tian T; Pan G; Wu F; Xiao L; Zhang L; Cai T; Wang X; Tannous BA; Li J; Kontos F; Ferrone S; Fan S
Clin Cancer Res; 2021 Jul; 27(13):3757-3771. PubMed ID: 33811153
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro.
Jin XF; Spöttl G; Maurer J; Nölting S; Auernhammer CJ
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33807122
[TBL] [Abstract][Full Text] [Related]
19. CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas.
Weich A; Werner RA; Buck AK; Hartrampf PE; Serfling SE; Scheurlen M; Wester HJ; Meining A; Kircher S; Higuchi T; Pomper MG; Rowe SP; Lapa C; Kircher M
Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33805264
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-34-CSF1R Signaling Axis Promotes Epithelial Cell Transformation and Breast Tumorigenesis.
Poudel M; Kim G; Bhattarai PY; Kim JY; Choi HS
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
